Day One Biopharmaceuticals, Inc. Cash Flow Statement

Cash Flow Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -142.16M-188.88M-204.71M
Depreciation and Depletion 0.02M0.02M0.06M
Share-based Compensation 0.11M0.53M13.32M27.24M39.34M48.26M
Gains from Investment Securities 30.00M0.94M2.55M
Cash from Operations -4.51M-13.49M-48.54M-109.87M-146.85M-78.11M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.14M0.18M2.03M10.08M6.39M
Amortization of Deferred Charges 2.08M0.03M
Depreciation & Amortization (CF) 0.02M0.02M0.06M0.04M0.09M
Change in Working Capital
Change in Receivables 13.88M
Change in Account Payables 0.01M0.13M1.54M-1.48M2.32M0.69M
Change in Accured Expenses 0.43M1.13M5.11M9.24M10.57M42.10M
Other Working Capital Changes -0.00M1.34M3.72M0.55M3.32M4.79M
Investing Activities
Capital Expenditures 0.09M0.03M0.22M20.00M
Sales of Property, Plant and Equipment 108.00M
Change in Intangibles 17.10M
Change in Acquisitions & Divestments 139.16M575.44M314.48M
Cash from Investing Activities -0.09M-8.00M-255.07M128.38M-230.99M
Financing Activities
Cash from Financing Activities 30.91M29.98M297.12M165.90M164.00M203.29M
Additional items
Change in Cash 26.39M16.40M240.58M-199.05M145.52M-105.82M
Free Cash Flow -4.51M-13.58M-48.54M-109.90M-147.08M-98.11M
Net Cash Flow 26.39M16.40M240.58M-199.05M145.52M-105.82M